Forced degradation of tacrolimus and the development of a UHPLC method for impurities determination

An ultra-high performance liquid chromatography method for simultaneous determination of tacrolimus impurities in pharmaceutical dosage forms has been developed. Appropriate chromatographic separation was achieved on a BEH C18 column using gradient elution with a total run time of 14 min. The method...

Full description

Saved in:
Bibliographic Details
Main Authors: Peterka Tanja Rozman, Lušin Tina Trdan, Bergles Jure, Ham Zoran, Grahek Rok, Urleb Uroš
Format: Article
Language:English
Published: Sciendo 2019-09-01
Series:Acta Pharmaceutica
Subjects:
Online Access:https://doi.org/10.2478/acph-2019-0025
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832574164083408896
author Peterka Tanja Rozman
Lušin Tina Trdan
Bergles Jure
Ham Zoran
Grahek Rok
Urleb Uroš
author_facet Peterka Tanja Rozman
Lušin Tina Trdan
Bergles Jure
Ham Zoran
Grahek Rok
Urleb Uroš
author_sort Peterka Tanja Rozman
collection DOAJ
description An ultra-high performance liquid chromatography method for simultaneous determination of tacrolimus impurities in pharmaceutical dosage forms has been developed. Appropriate chromatographic separation was achieved on a BEH C18 column using gradient elution with a total run time of 14 min. The method was applied to analyses of commercial samples and was validated in terms of linearity, precision, accuracy, sensitivity and specificity. It was found to be linear, precise and accurate in the range of 0.05 to 0.6 % of the impurities level in pharmaceutical dosage forms. Stability indicating power of the method was demonstrated by the results of forced degradation studies. The forced degradation study in solution revealed tacrolimus instability under stress alkaline, thermal, light and photolytic conditions and in the presence of a radical initiator or metal ions. The drug was stable at pH 3–5. Solid-state degradation studies conducted on amorphous tacrolimus demonstrated its sensitivity to light, elevated temperature, humidity and oxidation.
format Article
id doaj-art-54ec73a7ee72486f86dd35defad533fe
institution Kabale University
issn 1846-9558
language English
publishDate 2019-09-01
publisher Sciendo
record_format Article
series Acta Pharmaceutica
spelling doaj-art-54ec73a7ee72486f86dd35defad533fe2025-02-02T00:31:54ZengSciendoActa Pharmaceutica1846-95582019-09-0169336338010.2478/acph-2019-0025acph-2019-0025Forced degradation of tacrolimus and the development of a UHPLC method for impurities determinationPeterka Tanja Rozman0Lušin Tina Trdan1Bergles Jure2Ham Zoran3Grahek Rok4Urleb Uroš5Lek Pharmaceticals d.d.SI-1526Ljubljana, SloveniaLek Pharmaceticals d.d.SI-1526Ljubljana, SloveniaLek Pharmaceticals d.d.SI-1526Ljubljana, SloveniaLek Pharmaceticals d.d.SI-1526Ljubljana, SloveniaLek Pharmaceticals d.d.SI-1526Ljubljana, SloveniaLek Pharmaceticals d.d.SI-1526Ljubljana, SloveniaAn ultra-high performance liquid chromatography method for simultaneous determination of tacrolimus impurities in pharmaceutical dosage forms has been developed. Appropriate chromatographic separation was achieved on a BEH C18 column using gradient elution with a total run time of 14 min. The method was applied to analyses of commercial samples and was validated in terms of linearity, precision, accuracy, sensitivity and specificity. It was found to be linear, precise and accurate in the range of 0.05 to 0.6 % of the impurities level in pharmaceutical dosage forms. Stability indicating power of the method was demonstrated by the results of forced degradation studies. The forced degradation study in solution revealed tacrolimus instability under stress alkaline, thermal, light and photolytic conditions and in the presence of a radical initiator or metal ions. The drug was stable at pH 3–5. Solid-state degradation studies conducted on amorphous tacrolimus demonstrated its sensitivity to light, elevated temperature, humidity and oxidation.https://doi.org/10.2478/acph-2019-0025tacrolimusforced degradationuhplcimpuritiesstability
spellingShingle Peterka Tanja Rozman
Lušin Tina Trdan
Bergles Jure
Ham Zoran
Grahek Rok
Urleb Uroš
Forced degradation of tacrolimus and the development of a UHPLC method for impurities determination
Acta Pharmaceutica
tacrolimus
forced degradation
uhplc
impurities
stability
title Forced degradation of tacrolimus and the development of a UHPLC method for impurities determination
title_full Forced degradation of tacrolimus and the development of a UHPLC method for impurities determination
title_fullStr Forced degradation of tacrolimus and the development of a UHPLC method for impurities determination
title_full_unstemmed Forced degradation of tacrolimus and the development of a UHPLC method for impurities determination
title_short Forced degradation of tacrolimus and the development of a UHPLC method for impurities determination
title_sort forced degradation of tacrolimus and the development of a uhplc method for impurities determination
topic tacrolimus
forced degradation
uhplc
impurities
stability
url https://doi.org/10.2478/acph-2019-0025
work_keys_str_mv AT peterkatanjarozman forceddegradationoftacrolimusandthedevelopmentofauhplcmethodforimpuritiesdetermination
AT lusintinatrdan forceddegradationoftacrolimusandthedevelopmentofauhplcmethodforimpuritiesdetermination
AT berglesjure forceddegradationoftacrolimusandthedevelopmentofauhplcmethodforimpuritiesdetermination
AT hamzoran forceddegradationoftacrolimusandthedevelopmentofauhplcmethodforimpuritiesdetermination
AT grahekrok forceddegradationoftacrolimusandthedevelopmentofauhplcmethodforimpuritiesdetermination
AT urleburos forceddegradationoftacrolimusandthedevelopmentofauhplcmethodforimpuritiesdetermination